Regenxbio: Q3 Earnings Snapshot

ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Regenxbio Inc. (RGNX) on Wednesday reported a loss of $59.6 million in its third quarter.

On a per-share basis, the Rockville, Maryland-based company said it had a loss of $1.17.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.16 per share.

The biotechnology company posted revenue of $24.2 million in the period, beating Street forecasts. Four analysts surveyed by Zacks expected $21.4 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGNX at https://www.zacks.com/ap/RGNX

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up